Novo Holdings A/S Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001388325

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q1 2025 · 31 positions · Total reported value $1.31B · Top-10 concentration 74.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 40.7% · 2 new · 8 cut · 1 exited

Active Share (vs S&P 500): 99.7% · vs QQQ: 99.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -12.9% · vs SPY -15.1% · Prev Value $1.72B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.6% · vs SPY -2.8% · Latest Value $1.49B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, Novo Holdings A/S disclosed 31 equity positions with a combined reported value of $1.31B. The filing implies a focused portfolio: its ten largest positions account for 74.1% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were VTI ($285.44M), BN ($122.16M), EWTX ($117.70M). By sector, the heaviest allocations are Health Care 40.5%, Technology 14.1%. Versus the prior quarter, allocation shifted toward Other (+3.8pp), Health Care (+3.5pp) and away from Industrials (-1.0pp), Technology (-7.3pp).

Versus the prior quarter, Novo Holdings A/S opened 2 new positions, trimmed 8 and fully exited 1, a turnover rate of 40.7% of positions. The portfolio's overlap with the prior quarter was 91% of names.

Of the 1 positions fully exited versus the prior quarter, the largest were TEM ($137.55M), CRGX ($23.99M), MRSN ($6.08M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • TEM TEMPUS AI INC · prev qtr: $137.55M
  • CRGX CARGO THERAPEUTICS INC · prev qtr: $23.99M
  • MRSN MERSANA THERAPEUTICS INC · prev qtr: $6.08M

Insider Transactions (Form 4)

Latest Novo Holdings A/S buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-05-04 Conversion Hemab Therapeutics Holdings, Inc. 4,180,550 — SEC filing
2026-05-01 Buy Avalyn Pharma Inc. 555,555 $18.00 SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 3,327,734 — SEC filing

All insider transactions →

Fund Profile

Novo Holdings A/S files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 26 positions worth $1.49B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 26 positions · $1.49B reported value (Q3 2026)
  • Top 10 holdings = 76.1% of reported value
  • Largest position: EWTX (EDGEWISE THERAPEUTICS INC) at 14.6%
  • Average position size: $57.30M

Sector Tilt

  • Health Care 67.0%
  • Information Technology 17.7%
  • Real Estate 10.9%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 2 new, 6 added, 8 reduced, 1 exited
  • 10 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 40.5%
Technology 14.1%
Other 32.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.04M $285.44M 21.71%
21.71%
Hold
2 2.33M $122.16M 9.29%
9.29%
Reduce
3 5.35M $117.70M 8.95%
8.95%
Add
4 165.84K $109.89M 8.36%
8.36%
Hold
5 272.80K $73.21M 5.57%
5.57%
Reduce
6 1.50M $67.58M 5.14%
5.14%
Hold
7 724.67K $55.28M 4.21%
4.21%
Hold
8 9.67M $51.13M 3.89%
3.89%
Reduce
9 372.33K $49.23M 3.75%
3.75%
Reduce
10 1.27M $42.76M 3.25%
3.25%
Add
11 490.00K $34.64M 2.63%
2.63%
Hold
12 1.87M $34.62M 2.63%
2.63%
Add
13 915.00K $34.55M 2.63%
2.63%
Add
14 789.13K $33.21M 2.53%
2.53%
Add
15 2.25M $30.33M 2.31%
2.31%
Hold
16 1.73M $27.08M 2.06%
2.06%
Hold
17 2.75M $22.44M 1.71%
1.71%
Add
18 1.20M $21.78M 1.66%
1.66%
Add
19 228.80K $20.25M 1.54%
1.54%
Add
20 2.21M $17.50M 1.33%
1.33%
Add
21 880.00K $16.90M 1.29%
1.29%
Add
22 3.00M $13.71M 1.04%
1.04%
Add
23 1.10M $7.34M 0.56%
0.56%
Hold
24 1.95M $6.30M 0.48%
0.48%
Add
25 1.12M $3.90M 0.30%
0.30%
Hold
26 15.81M $3.83M 0.29%
0.29%
Hold
27 3.35M $3.66M 0.28%
0.28%
Hold
28 1.85M $3.57M 0.27%
0.27%
Hold
29 1.13M $2.51M 0.19%
0.19%
Hold
30 441.56K $1.82M 0.14%
0.14%
Hold
31 99.91K $309.73K 0.02%
0.02%
Hold

FAQ

What did Novo Holdings A/S buy in 2025-Q1?

In its 2025-Q1 13F filing, Novo Holdings A/S reported 31 equity positions worth $1.31B in aggregate; its largest disclosed positions were VTI ($285.44M), BN ($122.16M), EWTX ($117.70M).

How large is Novo Holdings A/S's portfolio?

Novo Holdings A/S reported $1.31B of long equity holdings across 31 positions as of 2025-Q1. Top-10 holdings account for 74.1% of reported value.

What is Novo Holdings A/S's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/novo-holdings-a-s/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →